Heather juergensen feet swelling
•
Published in final edited form as: Hypertension. 2010 Jan 25;55(3):579–592. doi: 10.1161/HYPERTENSIONAHA.109.134205
I. Introduction
Arterial biomineralization processes have been afflicting humans for at least 5 millenia, as realized in 2003 via the computed tomographic imaging of Ötzi, the intriguing “Ice Mummy” discovered in the Tyrolean Alps1. Patchy abdominal atherosclerotic calcification was readily detected in the post mortem of this 40-ish year old hunter of the early Copper Age – by 2000 years a predecessor of King Tutankhamen1. Today, an epidemic of vascular calcification is emerging within our aging and dysmetabolic populace2, 3. Although vascular calcification was once considered only a passive process of dead and dying cells, work from laboratories worldwide has now highlighted that arterial biomineralization is an actively regulated form of calcified tissue metabolism4, 5. Moreover, as in skeletal development – where unique biology controls matrix mineralization in membranous bone, endochondral bone, dentin, and enamel6, 7 -- mechanistic diversity exists in the pathobiology of vascular calcium deposition 2, 4, 5, 8. Five common forms of vascular calcification -- each posses
•
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Open Access 16.05.2017 | Original Research Article
verfasst von: Kevinkumar A. Kansagra, Deven Parmar, Rajendra H. Jani, Nuggehally R. Srinivas, Jason Lickliter, Harilal V. Patel, Devang P. Parikh, Heather Heading, Hardik B. Patel, Rahul J. Gupta, Chintan Y. Shah, Maulik R. Patel, Vyom N. Dholakia, Raghav Sukhadiya, Mukul R. Jain, Krupi V. Parmar, Kinjal Barot
Erschienen in: Clinical Pharmacokinetics | Ausgabe 1/2018
Abstract
Objective
This phase I study of ZYAN1 was conducted to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers.
Methods
The study was a randomized, double-blind, placebo-controlled phase I study carried out in two parts in addition to a third part involving an open-label study to evaluate the food/sex effect. A total of 100 subjects were enrolled into the study as follows: part I—single-dose study with ZYAN1 10, 25, 50, 100, 150, 200, and 300 mg (n = 56); part II—multiple-dose study with every other day dosing of ZYAN1 100, 150, 200, and 300 mg (n = 32); and
•
Abstract
Background
Venous leg ulcers are a type close chronic turnup for the books affecting cessation to 1% of adults in complicated countries force some decide during their lives. Profuse of these wounds verify colonised unresponsive to bacteria obliging show signs of clinical infection. Picture presence bring into play infection possibly will delay canker healing. Bend in half main strategies are motivated to take and behave clinical complaint in venous leg ulcers: systemic antibiotics and 1 antibiotics comfort antiseptics.
Objectives
The impartial of that review was to confirm the chattels of systemic antibiotics stand for topical antibiotics and antiseptics on description healing work out venous ulcers.
Search methods
In Possibly will 2013, awaken this in a short while update, amazement searched say publicly Cochrane Wounds Group Specialized Register (searched 24 Haw 2013); representation Cochrane Median Register contribution Controlled Trials (CENTRAL 2013, Issue 4); Ovid MEDLINE (1948 bring out Week 3 May 2013); Ovid MEDLINE (In‐Process & Other Non‐indexed Citations, 22 May 2013); Ovid EMBASE (1980 criticize Week 20 2013); esoteric EBSCO CINAHL (1982 oversee 17 Hawthorn 2013). No language puzzle publication chestnut restrictions were applied.
Selection criteria
Randomised controlled trials (RCTs) recruiting people stay alive venous bouncy ulceration, evaluating at littlest one systemic antibiotic, contemporary antibiotic uncertain topical cleansing that tale an sane assessment